F&P Healthcare's latest innovation: ResMed acquires MEDX to expand its sleep and respiratory care solutions

F&P Healthcare, a global leader in the development and manufacture of innovative healthcare solutions, has recently acquired MEDX, a leading provider of sleep and respiratory care products. This acquisition strengthens F&P Healthcare's position as a leading provider of comprehensive sleep and respiratory care solutions.

MEDX's range of products includes CPAP and BiPAP machines, oxygen concentrators, and nebulizers. This acquisition will allow F&P Healthcare to offer a more comprehensive range of products and services to its customers, including hospitals, clinics, and homecare providers.

In addition to expanding its product portfolio, the acquisition will also give F&P Healthcare access to MEDX's strong distribution network. This will allow F&P Healthcare to reach a wider range of customers and provide better access to its products and services.

The acquisition is a significant step in F&P Healthcare's strategy to become a global leader in sleep and respiratory care. The company has been investing heavily in research and development, and the acquisition of MEDX will accelerate its growth in this market.

Benefits of the acquisition for F&P Healthcare

• Expands F&P Healthcare's product portfolio with CPAP and BiPAP machines, oxygen concentrators, and nebulizers.
• Gives F&P Healthcare access to MEDX's strong distribution network.
• Accelerates F&P Healthcare's growth in the sleep and respiratory care market.

Benefits of the acquisition for MEDX

• Provides MEDX with access to F&P Healthcare's global reach and resources.
• Lets MEDX to continue to develop and market its innovative products under the F&P Healthcare brand.
• Gives MEDX the opportunity to expand its reach into new markets.

The acquisition is expected to be completed in the first quarter of 2023. Financial terms of the deal were not disclosed.

F&P Healthcare